EU post-market surveillance and QP role among list of Council’s big changes to be mulled
This article was originally published in Clinica
Executive Summary
The burden on medtech manufacturers to follow up the quality, performance and safety of their devices that are on the market could get heavier, if proposals by the Council of the EU for the forthcoming Medical Device Regulation are to go ahead.